Cosmo Pharmaceuticals N.V.
0RGI.L
Price:
$61.2
Market Cap:
$1.05B
Cosmo Pharmaceuticals N.V., a specialty pharmaceutical company, focuses on the development and commercialization products for gastroenterology and endoscopy worldwide. It offers Lialda/Mezavant/Mesavancol and UCERIS/Cortiment, an oral tablet formulation for remission in active, mild to moderate ulcerative colitis; GI Genius, a system that uses artificial intelligence to detect colorectal polyps; and Methylene Blue MMX, diagnostic drug to enhance pre-cancerous and cancerous detection of colorectal lesions during colonoscopy. The company also provides Eleview, an injectable composition for use in gastrointestinal endoscopic procedures for submucosal lift of polyps, adenomas, early-stage cancer...[Read more]
Industry
Medical - Pharmaceuticals
IPO Date
2016-05-20
Stock Exchange
LSE
Ticker
0RGI.L
PE Ratio
[46.90]
ROE
[13.96%]
Current Ratio
[4.19]
Dividend Yield
[2.92%]
Enterprise Value
[1.01B]
Dividend History
The ROE as of July 2025 (TTM) for Cosmo Pharmaceuticals N.V. (0RGI.L) is 13.96%
According to Cosmo Pharmaceuticals N.V.’s latest financial reports and current stock price. The company's current ROE is 13.96%. This represents a change of 296.86% compared to the average of 3.52% of the last 4 quarters.
Cosmo Pharmaceuticals N.V. (0RGI.L) Historical ROE (quarterly & annually)
How has 0RGI.L ROE performed in the past?
The mean historical ROE of Cosmo Pharmaceuticals N.V. over the last ten years is 8.06%. The current 13.96% ROE has changed 73.19% with respect to the historical average. Over the past ten years (40 quarters), 0RGI.L's ROE was at its highest in in the December 2005 quarter at 66.40%. The ROE was at its lowest in in the June 2005 quarter at -336.55%.
Average
8.06%
Median
1.30%
Minimum
-6.90%
Maximum
61.49%
Cosmo Pharmaceuticals N.V. (0RGI.L) ROE by Quarter and Year
Discovering the peaks and valleys of Cosmo Pharmaceuticals N.V. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 52.88%
Maximum Annual ROE = 61.49%
Minimum Annual Increase = -2388.54%
Minimum Annual ROE = -6.90%
| Year | ROE | Change |
|---|---|---|
| 2024 | 26.74% | -2388.54% |
| 2023 | -1.17% | -130.99% |
| 2022 | 3.77% | -12.11% |
| 2021 | 4.29% | -317.21% |
| 2020 | -1.97% | -68.26% |
| 2019 | -6.22% | 52.88% |
| 2018 | -4.07% | -41.04% |
| 2017 | -6.90% | -248.30% |
| 2016 | 4.65% | -92.43% |
| 2015 | 61.49% | 27.70% |
Cosmo Pharmaceuticals N.V. (0RGI.L) Average ROE
How has 0RGI.L ROE performed in the past?
The current ROE of Cosmo Pharmaceuticals N.V. (0RGI.L) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
9.78%
5-year avg
6.33%
10-year avg
8.06%
Cosmo Pharmaceuticals N.V. (0RGI.L) ROE vs. Peers
How is 0RGI.L’s ROE compared to its peers?
Cosmo Pharmaceuticals N.V.’s ROE is
| Company | ROE | Market cap |
|---|
Build a custom stock screener for Cosmo Pharmaceuticals N.V. (0RGI.L) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Cosmo Pharmaceuticals N.V. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Cosmo Pharmaceuticals N.V. (0RGI.L) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Cosmo Pharmaceuticals N.V. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Cosmo Pharmaceuticals N.V.'s ROE?
How is the ROE calculated for Cosmo Pharmaceuticals N.V. (0RGI.L)?
What is the highest ROE for Cosmo Pharmaceuticals N.V. (0RGI.L)?
What is the 3-year average ROE for Cosmo Pharmaceuticals N.V. (0RGI.L)?
What is the 5-year average ROE for Cosmo Pharmaceuticals N.V. (0RGI.L)?
How does the current ROE for Cosmo Pharmaceuticals N.V. (0RGI.L) compare to its historical average?